Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease
The Korean Journal of Internal Medicine
;
: 73-75, 2009.
Artigo
em Inglês
| WPRIM
| ID: wpr-12975
ABSTRACT
The prognosis of patients with end-stage renal disease has improved with advances in hemodialysis techniques. However, many patients who undergo hemodialysis suffer from various types of cancer. Limited data is available to guide clinical management of these patients who may have impaired renal function. Here, we report our experience with the use of irinotecan for the treatment of a hemodialysis patient with small-cell lung cancer and end-stage renal disease.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Camptotecina
/
Seguimentos
/
Diálise Renal
/
DNA Topoisomerases Tipo I
/
Intervalo Livre de Doença
/
Carcinoma de Pequenas Células do Pulmão
/
Falência Renal Crônica
/
Neoplasias Pulmonares
/
Antineoplásicos Fitogênicos
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
The Korean Journal of Internal Medicine
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS